InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-12 · accession 0000950170-24-127316 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-14 2024-11-12 HCA Billington Phillip G SVP-Internal Audit Services M - OptEx $68.96 +8,000 60.7K +15% +$551.7K
D 2024-11-14 2024-11-14 HCA Billington Phillip G SVP-Internal Audit Services S - Sale+OE $350.00 -3,897 52.7K -7% -$1.36M
D 2024-11-14 2024-11-12 HCA Billington Phillip G SVP-Internal Audit Services F - Tax $350.53 -4,103 56.6K -7% -$1.44M
D 2024-11-14 2024-11-12 HCA Billington Phillip G SVP-Internal Audit Services M - OptEx $0.00 -8,000 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-12 M A 8,000 $68.96 60,702.07 D — — (F1) Includes 2,367.0749 shares acquired under the Issuer's employee stock purchase plans.
2 Common Common Stock 2024-11-14 S D 3,897 $350.00 52,702.07 D — — (F1) Includes 2,367.0749 shares acquired under the Issuer's employee stock purchase plans.
3 Common Common Stock 2024-11-12 F D 4,103 $350.53 56,599.07 D — — (F1) Includes 2,367.0749 shares acquired under the Issuer's employee stock purchase plans.
4 Derivative Stock Appreciation Right 2024-11-12 M D 8,000 $0.00 0 D $68.96 · — to 2025-02-04 8,000 Common Stock (F2) The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016